ArticleThe Lancet regional health. Europe2026
Frequency and survival of delayed breast cancer diagnosis in women participating at screening mammography in the Netherlands: a population-based study.
Article in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Increased Axillary Nodal Metastasis in Patients with Breast Cancer and Limited English Proficiency.Annals of surgical oncology · 2026Article
- Semantic Segmentation for Pixel-Wise Visualization of Breast Cancer in Deep Ultraviolet-Excited Fluorescence Images.Acta histochemica et cytochemica · 2026Article
- Global comparison of breast cancer burden between women aged 20-54 and ≥55 years (1990-2021).Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although breast cancer screening programmes aim to enable early breast cancer detection, diagnostic delays still occur among participants. Limited information is available on the frequency and survival of women with a delay in breast cancer diagnosis within the screening population. We determined the frequency of various types of delay in breast cancer diagnosis at screening mammography and specified the tumour characteristics, surgical therapy and survival rates of women with these delayed diagnoses, as well as variations in their proportions over time. Methods: We included 901,133 screening examinations obtained in the southern Netherlands between 1999 and 2019. Screening mammograms of women with interval cancers (ICs) and breast cancers detected at subsequent screening were reviewed to determine whether the cancer had been missed. Findings: Of the 7129 women with breast cancers, 5419 (76.0%) were diagnosed without delay after recall and 1101 (15.4%) had a true IC (i.e., not detectable at the previous screen). In total, 1601 women experienced a delay in breast cancer diagnosis, comprising the following three study groups: (i) recalled women with a delay in diagnostic work-up (n = 264), (ii) recalled women with screen-detected cancers (SDCs) at subsequent screening and without a delay in diagnostic work-up, that had been missed at the previous screening round (n = 992), and (iii) women with ICs missed at the latest screening round (n = 345). Overall, 26.6% of cancers were associated with a delay (1601/6028), primarily due to SDCs missed at the previous screen (62.0%, 992/1601), followed by missed ICs (21.5%, 345/1601) and misdiagnosis after recall (16.5%, 264/1601). Compared to SDCs missed at the previous screen and misdiagnosis after recall, missed ICs demonstrated the poorest tumour characteristics, highest mastectomy rate (42.6% vs 20.1% and 19.3%, p < 0.0001) and poorest overall survival (5-year rate 86.9% vs 93.8% and 93.8%, p = 0.0017). Temporal trends in tumour characteristics were mainly observed in SDCs missed at the previous screen. Interpretation: Delayed breast cancer diagnosis at screening mammography or after recall remains a serious point of concern. Most delays are related to SDCs missed at a previous screen, whereas missed ICs show the worst survival. Funding: This research did not receive any funding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.